Literature DB >> 27247531

Perioperative Considerations in Crohn Disease and Ulcerative Colitis.

T Paul Nickerson1, Amit Merchea2.   

Abstract

The management of inflammatory bowel disease (IBD) is medically and surgically complex. Numerous patient- and disease-oriented factors must be considered in treating patients with IBD, including nutritional replenishment/support, effect of immunosuppressive medications, extent of resection, and use of proximal diversion. Perioperative planning and optimization of the patient is imperative to ensuring favorable outcomes and limiting morbidity. These perioperative considerations in Crohn disease and ulcerative colitis are reviewed here.

Entities:  

Keywords:  Crohn disease; biologics; immunomodulators; nutrition; perioperative management; steroids; ulcerative colitis

Year:  2016        PMID: 27247531      PMCID: PMC4882174          DOI: 10.1055/s-0036-1580633

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  51 in total

1.  The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.

Authors:  L Marchal; G D'Haens; G Van Assche; S Vermeire; M Noman; M Ferrante; M Hiele; M Bueno De Mesquita; A D'Hoore; F Penninckx; P Rutgeerts
Journal:  Aliment Pharmacol Ther       Date:  2004-04-01       Impact factor: 8.171

2.  Outcomes of ileocolic resection and right hemicolectomies for Crohn's patients in comparison with non-Crohn's patients and the impact of perioperative immunosuppressive therapy with biologics and steroids on inpatient complications.

Authors:  Christopher Mascarenhas; Robert Nunoo; Theodor Asgeirsson; Rachelle Rivera; Don Kim; Rebecca Hoedema; Nadav Dujovny; Martin Luchtefeld; Alan T Davis; Ryan Figg
Journal:  Am J Surg       Date:  2012-03       Impact factor: 2.565

3.  Adrenal atrophy and irreversible shock associated with cortisone therapy.

Authors:  C G FRASER; F S PREUSS; W D BIGFORD
Journal:  J Am Med Assoc       Date:  1952-08-23

4.  Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?

Authors:  J Canedo; S-H Lee; R Pinto; S Murad-Regadas; L Rosen; S D Wexner
Journal:  Colorectal Dis       Date:  2011-11       Impact factor: 3.788

5.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

Review 6.  Preoperative optimization of crohn disease.

Authors:  Amit Sharma; Bertram T Chinn
Journal:  Clin Colon Rectal Surg       Date:  2013-06

7.  Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients.

Authors:  Adrian A Indar; Tonia M Young-Fadok; Jacques Heppell; Jonathan E Efron
Journal:  World J Surg       Date:  2009-05       Impact factor: 3.352

8.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Authors:  Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

9.  A prospective, randomized, noninferiority trial of steroid dosing after major colorectal surgery.

Authors:  Karen Zaghiyan; Gil Y Melmed; Dror Berel; Gayane Ovsepyan; Zuri Murrell; Phillip Fleshner
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

10.  Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty.

Authors:  Grace S Tay; David G Binion; Daniel Eastwood; Mary F Otterson
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

View more
  3 in total

1.  A contemporary series of surgical outcomes following subtotal colectomy and/or completion proctectomy for management of inflammatory bowel disease.

Authors:  Lucy Burns; Michael E Kelly; Maria Whelan; James O'Riordan; Paul Neary; Dara O Kavanagh
Journal:  Ir J Med Sci       Date:  2022-01-17       Impact factor: 1.568

Review 2.  Preoperative Nutritional Conditioning of Crohn's Patients-Systematic Review of Current Evidence and Practice.

Authors:  Fabian Grass; Basile Pache; David Martin; Dieter Hahnloser; Nicolas Demartines; Martin Hübner
Journal:  Nutrients       Date:  2017-06-01       Impact factor: 5.717

Review 3.  Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support.

Authors:  Patrick L Stoner; Amir Kamel; Fares Ayoub; Sanda Tan; Atif Iqbal; Sarah C Glover; Ellen M Zimmermann
Journal:  Gastroenterol Res Pract       Date:  2018-09-23       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.